Skip to main content
. 2023 Apr 5;42(20):1649–1660. doi: 10.1038/s41388-023-02683-w

Fig. 4. RAF1 depletion impacts patient-derived organoids proliferation.

Fig. 4

A Representative pictures of four patient-derived organoids stably transduced with inducible RAF1 shRNA. Addition of doxycycline (0.5 µg/ml), induces the expression of GFP and of RAF1 shRNA. Scale bars = 250 µm. B Comparison of PDOs volume in Dox-induced/uninduced organoids expressing a control shRNA or two independent RAF1 shRNA. Experiments were performed in triplicate at least three times. C Immunoblot showing RAF, MEK and ERK status in Dox-induced PDOs. Tubulin or GAPDH were used as loading controls. D Patient-derived organoids were treated for 8 days with either DMSO (vehicle) or 1 µM GW5074 prior to end volume determination. The experiment was repeated three times. B, D, *p < 0.05, **p < 0.01, ***p < 0.001, n.s not significant.